Monthly Archives: April 2016

//April

DH releases slides from stakeholder event

The Department of Health (DH) today (28th April) held a stakeholder engagement event on its consultation on the future of community pharmacy. At the event a series of slides were presented and DH has provided the stakeholders with copies to share with their members. Consultation event slides: Community pharmacy in 2016/17 and beyond The event gave the...

By |April 28th, 2016|Lexpos News|Comments Off on DH releases slides from stakeholder event

Class 4 MHRA drug alert — Crestor 5 mg tablets (Provisacor)

Drug alert number: EL (16)A/03 Date issued: 28th April 2016 The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 4 pharmacy level Caution in Use drug alert for certain batches of: Crestor 5mg Tablets Parallel Imported by BR Lewis Pharmaceuticals Ltd (Originator name Provisacor), pack size 2 x 14 PI Batch Number: S347A/3153...

By |April 28th, 2016|Lexpos News|Comments Off on Class 4 MHRA drug alert — Crestor 5 mg tablets (Provisacor)

Technical issues with our online register

We're currently experiencing some technical issues with our online register. We are hoping to resolve those soon but please accept our apologies for the inconvenience. In the meantime, if you require urgent access to the information on our register, please email info@pharmacyregulation.org.

 

By |April 28th, 2016|Lexpos News|Comments Off on Technical issues with our online register

Three new GPhC council members take up their positions

Three new members have taken up their positions on the governing council of the General Pharmaceutical Council (GPhC). 

The three new members, whose terms began on 1 April 2016, include one registrant member, Joanne Kember, and two lay members, Mark Hammond and Dr Arun Midha. Nigel Clarke, Chair of the GPhC, said:

By |April 28th, 2016|Lexpos News|Comments Off on Three new GPhC council members take up their positions

Change to the listings for Midazolam oromucosal solution pre-filled oral syringes in May Drug Tariff

Contractors should be aware of changes to the May Drug Tariff and dm+d listings of Midazolam oromucosal solution pre-filled oral syringes. Effective from 1st May 2016, the listings for the following four Part VIIIA entries of Midazolam oromucosal solution pre-filled oral syringes will change to recognise the sugar free (SF) status of this product. The...

By |April 27th, 2016|Lexpos News|Comments Off on Change to the listings for Midazolam oromucosal solution pre-filled oral syringes in May Drug Tariff